Related Experiment Video
Updated: Jun 27, 2025

10:19
Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells
Published on: May 12, 2023
1.2K
Applications and challenges in designing VHH-based bispecific antibodies: leveraging machine learning solutions
Michael Mullin1, James McClory1, Winston Haynes1
1LabGenius, London, UK.
Mabs
|April 26, 2024
Summary
Camelid-derived variable heavy domain of heavy chain (VHH) antibodies offer modularity for constructing bispecific antibodies. Machine learning aids in optimizing VHH antibody development for enhanced therapeutic quality and performance.
Area of Science:
- Biotechnology
- Immunology
- Computational Biology
Background:
- Bispecific antibodies require diverse binding domains for therapeutic efficacy.
- Single-domain antibodies, especially VHH, are valuable for bispecific antibody construction due to their unique properties.
Purpose of the Study:
- To review the application of VHH domains in multispecific antibody development.
- To explore challenges and advancements in creating optimized VHH-based bispecific antibodies.
Main Methods:
- Review of traditional VHH antibody development approaches.
- Integration of machine learning (ML) in VHH antibody engineering.
- Application of ML for structural prediction, lead identification, optimization, and humanization.
Main Results:
- VHH domains provide modularity and favorable biophysical properties for bispecific antibody design.
- Machine learning significantly enhances various stages of VHH antibody development.
- ML integration addresses challenges in creating high-quality, optimized multispecific antibodies.
Conclusions:
- VHH domains are versatile building blocks for advanced bispecific antibody therapeutics.
- Machine learning is crucial for overcoming hurdles in VHH antibody optimization and humanization.
- Optimized VHH-based bispecific antibodies hold significant therapeutic potential.

